Controlled attenuation parameter for assessment of hepatic steatosis grades: A diagnostic meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 10, 2015, Pages 17654-17663

  Wang, Yuee ^a   Fan, Qingqi ^a   Wang, Ting ^a   Wen, Jia ^a   Wang, Hong ^a   Zhang, Tiansong ^b  

^a Central Hospital in jing'An District   (China)

^b Jing an District Central Hospital   (China)

Author keywords

Controlled attenuation parameter; Diagnostic meta analysis; Hepatic steatosis

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; ATTENUATION; BIBLIOGRAPHIC DATABASE; CHRONIC HEPATITIS C; DIAGNOSTIC ACCURACY; DISEASE ASSESSMENT; FATTY LIVER; HEPATITIS B; HUMAN; INFORMATION PROCESSING; META ANALYSIS; NONALCOHOLIC FATTY LIVER; PUBLICATION; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84949663847     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sasso M, Miette V, Sandrin L and Beaugrand M. The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®. Clin Res Hepatol Gastroenterol 2012; 36: 13-20.
2. Valenti L, Fracanzani AL, Bugianesi E, Dongiovanni P, Galmozzi E, Vanni E, Canavesi E, Lattuada E, Roviaro G and Marchesini G. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 2010; 138: 905-912.
3. Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M and Miyazoe S. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 2003; 97: 3036-3043.
4. David K, Kowdley KV, Unalp A, Kanwal F, Brunt EM, Schwimmer JB; NASH CRN Research Group. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 2009; 1904-1912.
5. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC and Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013; 58: 593-608.
6. Farrell GC and Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112.
7. Grandison GA and Angulo P. Can NASH be diagnosed, graded, and staged noninvasively? Clin Liver Dis 2012; 16: 567-585.
8. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC and Smith AD. Liver biopsy. Hepatology 2009; 49: 1017-1044.
9. Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH and Sung MW. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Digest Liver Dis 2010; 42: 503-508.
10. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A and Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33.
11. Wong VW, Vergniol J, Wong GLH, Foucher J, Chan HLY, Le Bail B, Choi PC, Kowo M, Chan AWH and Merrouche W. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-462.
12. Sasso M, Beaugrand M, De Ledinghen V, Douvin C, Marcellin P, Poupon R, Sandrin L and Miette V. Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound in Medicine & Biology 2010; 36: 1825-1835.
13. Shi KQ, Tang JZ, Zhu XL, Ying L, Li DW, Gao J, Fang YX, Li GL, Song YJ and Deng ZJ. Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: A meta-analysis of diagnostic accuracy. J Gastroenterol Hepatol 2014; 29: 1149-1158.
14. Zamora J, Abraira V, Muriel A, Khan K and Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6: 31.
15. Myers RP, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M, Duarte-Rojo A, Wong D, Crotty P and Elkashab M. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int 2012; 32: 902-910.
16. Lédinghen V, Vergniol J, Foucher J, Merrouche W and Bail B. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int 2012; 32: 911-918.
17. Sasso M, Tengher-Barna I, Ziol M, Miette V, Fournier C, Sandrin L, Poupon R, Cardoso AC, Marcellin P and Douvin C. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C. J Viral Hepat 2012; 19: 244-253.
18. Kumar M, Rastogi A, Singh T, Behari C, Gupta E, Garg H, Kumar R, Bhatia V and Sarin SK. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: Does etiology affect performance? J Gastroenterol Hepatol 2013; 28: 1194-1201.
19. Masaki K, Takaki S, Hyogo H, Kobayashi T, Fukuhara T, Naeshiro N, Honda Y, Nakahara T, Ohno A and Miyaki D. Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases. Hepatol Res 2013; 43: 1182-1189.
20. Wang CY, Lu W, Hu DS, Wang GD and Cheng XJ. Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B. World J Gastroenterol 2014; 20: 10585.
21. Shen F, Zheng RD, Mi YQ, Wang XY, Pan Q, Chen GY, Cao HX, Chen ML, Xu L and Chen JN. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients. World J Gastroenterol 2014; 20: 4702.
22. Chan WK, Mustapha N, Raihan N and Mahadeva S. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2014; 29: 1470-1476.
23. Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim DY, Ahn SH, Chon CY, Lee HW and Park Y. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver International 2014; 34: 102-109.
24. Ferraioli G, Tinelli C, Lissandrin R, Zicchetti M, Dal Bello B, Filice G and Filice C. Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis. World J Gastroenterol 2014; 20: 6626.
25. Bohte AE, van Werven JR, Bipat S and Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Europ Radiol 2011; 21: 87-97.
26. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J and Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009; 51: 433-445.
27. Meek D, Mills P, Gray H, Duncan J, Russell R and McKillop J. A comparison of computed tomography, ultrasound and scintigraphy in the diagnosis of alcoholic liver disease. Br J Radiol 1984; 57: 23-27.
28. Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, Ha HK, Lee MG, Hwang S and Lee SG. Macrovesicular Hepatic Steatosis in Living Liver Donors: Use of CT for Quantitative and Qualitative Assessment 1. Radiology 2006; 239: 105-112.
29. Birnbaum BA, Hindman N, Lee J and Babb JS. Multi-Detector Row CT Attenuation Measurements: Assessment of Intra-and Interscanner Variability with an Anthropomorphic Body CT Phantom 1. Radiology 2007; 242: 109-119.
30. Wong GL, Wong VW, Lai JW, Chim AM and Chan HL. Journal of gastroenterology and hepatology. 111 River ST, Hoboken 07030-5774, NJ USA: Wiley-Blackwell; 2012. Vol. 27. pp. 239-240.
31. Enooku K, Tateishi R, Fujiwara N, Mikami S, Minami T, Sato M, Uchino K, Kondo Y, Yoshida H and Ikeda H. 1330 Non-invasive measurement of liver steatosis by controlled attenuation parameter (CAP) using Fibroscan® in patients with nonalcoholic fatty liver disease (NAFLD) (NAFLD). J Hepatol 2013; 58: S536-S537.
32. Friedrich-Rust M, Romen D, Vermehren J, Kriener S, Sadet D, Herrmann E, Zeuzem S and Bojunga J. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Europ J Radiol 2012; 81: e325-e331.